Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 9,150.00
-850.00 (-8.50%)
At close: Mar 31, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 118.46 billion as of April 1, 2026. Its market cap has increased by 22.00% in one year.
Market Cap
118.46B
Enterprise Value
100.39B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,150.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has increased from 112.78B to 118.46B, an increase of 5.03%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 118.46B | -2.56% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 169.71B |
| Organoidsciences | 156.74B |
| Kyung Dong Pharmaceutical | 147.91B |
| DongKoo Bio & Pharma | 147.11B |
| PHARMARESEARCH BIO | 132.53B |
| KOREA PHARMA | 128.04B |
| HYUNDAI BIOLAND | 123.00B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.43B |